Literature DB >> 18551601

Prevalence of human metapneumovirus among hospitalized children younger than 1 year in Catalonia, Spain.

Marta Camps1, Sílvia Ricart, Veselka Dimova, Núria Rovira, Carmen Muñoz-Almagro, Juan Jose Garcia, Martí Pons-Odena, M Angeles Marcos, Tomàs Pumarola.   

Abstract

Human metapneumovirus was discovered recently respiratory virus implicated in both upper and lower respiratory tract infection. In children, the clinical symptoms of human metapneumovirus are similar to those produced by respiratory syncytial virus, ranging from mild to severe diseases such as bronchiolitis and pneumonia. The aim of the present study was to describe the prevalence of human metapneumovirus and other common respiratory viruses among admitted to hospital infants. From January 2006 to June 2006, 99 nasopharyngeal aspirates were collected from hospitalized children younger than 12 months in order to study respiratory viruses. Human metapneumovirus detection was performed by cell culture and two RT-PCR targeting on polymerase and fusion genes. The latter gene was used for phylogenetic analysis. In 67/99 children (67%) at least one viral pathogen was identified, the viruses detected most frequently were respiratory syncytial virus (35%), human metapneumovirus (25%) and rhinovirus (19%). The results obtained in this study, show that: (1) human metapneumovirus is one of the most important viruses among children less than 12 months; (2) children infected with human metapneumovirus were significantly older than those infected by respiratory syncytial virus; (3) human metapneumovirus was associated more frequently with pneumonia whereas respiratory syncytial virus was only detected in patients with bronchiolitis; (4) there was a clear epidemiological succession pattern with only a small overlap among the viruses detected most frequently; (5) all human metapneumovirus samples were clustered within sublineage A2.

Entities:  

Mesh:

Year:  2008        PMID: 18551601      PMCID: PMC7166915          DOI: 10.1002/jmv.21209

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  56 in total

1.  Detection of human metapneumovirus in clinical samples by immunofluorescence staining of shell vial centrifugation cultures prepared from three different cell lines.

Authors:  Marie L Landry; David Ferguson; Sandra Cohen; Teresa C T Peret; Dean D Erdman
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

2.  Comparison of human metapneumovirus, respiratory syncytial virus and influenza A virus lower respiratory tract infections in hospitalized young children.

Authors:  Dana G Wolf; David Greenberg; Davina Kalkstein; Yonat Shemer-Avni; Noga Givon-Lavi; Niveen Saleh; Miri D Goldberg; Ron Dagan
Journal:  Pediatr Infect Dis J       Date:  2006-04       Impact factor: 2.129

3.  Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children.

Authors:  John V Williams; Paul A Harris; Sharon J Tollefson; Lisa L Halburnt-Rush; Joyce M Pingsterhaus; Kathryn M Edwards; Peter F Wright; James E Crowe
Journal:  N Engl J Med       Date:  2004-01-29       Impact factor: 91.245

4.  Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research.

Authors:  L J Baraff; J W Bass; G R Fleisher; J O Klein; G H McCracken; K R Powell; D L Schriger
Journal:  Ann Emerg Med       Date:  1993-07       Impact factor: 5.721

5.  Detection and pathogenicity of human metapneumovirus respiratory infection in pediatric Italian patients during a winter--spring season.

Authors:  Antonella Sarasini; Elena Percivalle; Francesca Rovida; Giulia Campanini; Emilia Genini; Maria Torsellini; Stefania Paolucci; Fausto Baldanti; Antonietta Marchi; M Grazia Revello; Giuseppe Gerna
Journal:  J Clin Virol       Date:  2005-07-14       Impact factor: 3.168

6.  Detection and typing by molecular techniques of respiratory viruses in children hospitalized for acute respiratory infection in Rome, Italy.

Authors:  Alessandra Pierangeli; Massimo Gentile; Paola Di Marco; Paolo Pagnotti; Carolina Scagnolari; Simona Trombetti; Lelia Lo Russo; Valeria Tromba; Corrado Moretti; Fabio Midulla; Guido Antonelli
Journal:  J Med Virol       Date:  2007-04       Impact factor: 2.327

7.  Respiratory tract reinfections by the new human Metapneumovirus in an immunocompromised child.

Authors:  Gilles Pelletier; Pierre Déry; Yacine Abed; Guy Boivin
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

8.  Human metapneumovirus infection among children, Bangladesh.

Authors:  W Abdullah Brooks; Dean Erdman; Pauline Terebuh; Alexander Klimov; Doli Goswami; Amina Tahia Sharmeen; Tasnim Azim; Stephen Luby; Carolyn Bridges; Robert Breiman
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883

9.  Human Metapneumovirus as a causative agent of acute bronchiolitis in infants.

Authors:  Paraskevi Xepapadaki; Stelios Psarras; Apostolos Bossios; Maria Tsolia; Dimitrios Gourgiotis; Georgia Liapi-Adamidou; Andreas G Constantopoulos; Dimitrios Kafetzis; Nikolaos G Papadopoulos
Journal:  J Clin Virol       Date:  2004-07       Impact factor: 3.168

10.  Human bocavirus and acute wheezing in children.

Authors:  Tobias Allander; Tuomas Jartti; Shawon Gupta; Hubert G M Niesters; Pasi Lehtinen; Riikka Osterback; Tytti Vuorinen; Matti Waris; Annelie Bjerkner; Annika Tiveljung-Lindell; Bernadette G van den Hoogen; Timo Hyypiä; Olli Ruuskanen
Journal:  Clin Infect Dis       Date:  2007-02-14       Impact factor: 9.079

View more
  8 in total

Review 1.  Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology.

Authors:  John S Tregoning; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

2.  A placebo-controlled trial of Korean red ginseng extract for preventing influenza-like illness in healthy adults.

Authors:  Ki-Chan Ha; Min-Gul Kim; Mi-Ra Oh; Eun-Kyung Choi; Hyang-Im Back; Sun-Young Kim; Eun-Ok Park; Dae-Young Kwon; Hye-Jeong Yang; Min-Jeong Kim; Hee-Joo Kang; Ju-Hyung Lee; Kyung-Min Choi; Soo-Wan Chae; Chang-Seop Lee
Journal:  BMC Complement Altern Med       Date:  2012-02-08       Impact factor: 3.659

3.  Synthetic sulfonated derivatives of poly(allylamine hydrochloride) as inhibitors of human metapneumovirus.

Authors:  Justyna Ciejka; Paweł Botwina; Maria Nowakowska; Krzysztof Szczubiałka; Krzysztof Pyrc
Journal:  PLoS One       Date:  2019-03-28       Impact factor: 3.240

Review 4.  The Impact of RSV-Associated Respiratory Disease on Children in Asia.

Authors:  Maduja Vyanga Manike Divarathne; Rukshan Rafeek Ahamed; Faseeha Noordeen
Journal:  J Pediatr Infect Dis       Date:  2018-04-11       Impact factor: 0.293

5.  Respiratory viruses involved in influenza-like illness in a Greek pediatric population during the winter period of the years 2005-2008.

Authors:  Vasiliki Pogka; Athanasios Kossivakis; Antonios Kalliaropoulos; Afroditi Moutousi; Dionyssios Sgouras; Takis Panagiotopoulos; George P Chrousos; Maria Theodoridou; Vassiliki P Syriopoulou; Andreas F Mentis
Journal:  J Med Virol       Date:  2011-10       Impact factor: 2.327

Review 6.  Viral pneumonia.

Authors:  Olli Ruuskanen; Elina Lahti; Lance C Jennings; David R Murdoch
Journal:  Lancet       Date:  2011-03-22       Impact factor: 79.321

7.  Human Metapneumovirus: Epidemiology and genotype diversity in children and adult patients with respiratory infection in Córdoba, Argentina.

Authors:  Pamela Elizabeth Rodriguez; María Celia Frutos; María Pilar Adamo; Cecilia Cuffini; Jorge Augusto Cámara; María Gabriela Paglini; Laura Moreno; Alicia Cámara
Journal:  PLoS One       Date:  2020-12-28       Impact factor: 3.240

8.  Genetic variability of human metapneumo- and bocaviruses in children with respiratory tract infections.

Authors:  Vasiliki Pogka; Afroditi Moutousi; Athanasios Kossyvakis; Antonios Kalliaropoulos; Dionyssios N Sgouras; Maria Giannaki; Andreas F Mentis
Journal:  Influenza Other Respir Viruses       Date:  2013-11-07       Impact factor: 4.380

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.